Propranolol in acute intermittent porphyria
Twenty cases of acute intermittent porphyria were studied during the acute phase. Cardiovascular manifestations were noted in all the cases, with tachycardia in 20 and with hypertension in 17. Propranolol in doses ranging from 20--200 mg was given to all the cases and produced adequate control of ta...
Gespeichert in:
| Veröffentlicht in: | Postgraduate medical journal 1979-08, Vol.55 (646), p.546-547 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 547 |
|---|---|
| container_issue | 646 |
| container_start_page | 546 |
| container_title | Postgraduate medical journal |
| container_volume | 55 |
| creator | Menawat, A. S. Panwar, R. B. Kochar, D. K. Joshi, C. K. |
| description | Twenty cases of acute intermittent porphyria were studied during the acute phase. Cardiovascular manifestations were noted in all the cases, with tachycardia in 20 and with hypertension in 17. Propranolol in doses ranging from 20--200 mg was given to all the cases and produced adequate control of tachycardia and hypertension. At follow-up, smaller doses of propranolol were found to maintain the pulse rate and BP within normal limits and also to prevent acute attacks. |
| doi_str_mv | 10.1136/pgmj.55.646.546 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2428078</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3972277221</sourcerecordid><originalsourceid>FETCH-LOGICAL-b488t-2c39316d93edf370088b4adf2fbfffafaa62731daf1fec746da2da6bc868a92a3</originalsourceid><addsrcrecordid>eNqFkc1v1DAQxS1EgW3hzIXDSkgcirL1t50LEloKBVWFQ-E6miR2myWJg52g9r_HVapV4cJpRno_v5nxI-QloxvGhD4Zr_rdRqmNlnqjpH5EVkzqsqBG6cdkRanghZJGPCOHKe0oZcJI9pQ8UUyWgq3I228xjBGH0IVu3Q5rrOfJ5WZysW-nyQ3TegxxvL6NLT4nBx675F7c1yPy_ePp5fasOP_66fP2_XlRSWungtciW-umFK7xwlBqbSWx8dxX3nv0iJobwRr0zLvaSN0gb1BXtdUWS47iiLxbfMe56l1T5yUidjDGtsd4CwFb-FsZ2mu4Cr-BS26psdngzb1BDL9mlybo21S7rsPBhTmBkVZTU_IMvv4H3IU5Dvk4YMZQy4RgKlMnC1XHkFJ0fr8Ko3AXAtyFAEpBDgFyCPnFq4cX7Pnl17NcLHKbJnezVzH-BG2EUXDxYwtnTF2oL5db-JD544Wv8pj_zf4DXDehOg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1770813315</pqid></control><display><type>article</type><title>Propranolol in acute intermittent porphyria</title><source>MEDLINE</source><source>PubMed Central(OpenAccess)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Menawat, A. S. ; Panwar, R. B. ; Kochar, D. K. ; Joshi, C. K.</creator><creatorcontrib>Menawat, A. S. ; Panwar, R. B. ; Kochar, D. K. ; Joshi, C. K.</creatorcontrib><description>Twenty cases of acute intermittent porphyria were studied during the acute phase. Cardiovascular manifestations were noted in all the cases, with tachycardia in 20 and with hypertension in 17. Propranolol in doses ranging from 20--200 mg was given to all the cases and produced adequate control of tachycardia and hypertension. At follow-up, smaller doses of propranolol were found to maintain the pulse rate and BP within normal limits and also to prevent acute attacks.</description><identifier>ISSN: 0032-5473</identifier><identifier>EISSN: 1469-0756</identifier><identifier>DOI: 10.1136/pgmj.55.646.546</identifier><identifier>PMID: 514931</identifier><language>eng</language><publisher>England: The Fellowship of Postgraduate Medicine</publisher><subject>Acute Disease ; Blood Pressure - drug effects ; Drug Administration Schedule ; Heart Rate - drug effects ; Humans ; Porphyrias - drug therapy ; Porphyrias - physiopathology ; Propranolol - administration & dosage ; Propranolol - therapeutic use</subject><ispartof>Postgraduate medical journal, 1979-08, Vol.55 (646), p.546-547</ispartof><rights>Copyright BMJ Publishing Group LTD Aug 1979</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b488t-2c39316d93edf370088b4adf2fbfffafaa62731daf1fec746da2da6bc868a92a3</citedby><cites>FETCH-LOGICAL-b488t-2c39316d93edf370088b4adf2fbfffafaa62731daf1fec746da2da6bc868a92a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2428078/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2428078/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/514931$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Menawat, A. S.</creatorcontrib><creatorcontrib>Panwar, R. B.</creatorcontrib><creatorcontrib>Kochar, D. K.</creatorcontrib><creatorcontrib>Joshi, C. K.</creatorcontrib><title>Propranolol in acute intermittent porphyria</title><title>Postgraduate medical journal</title><addtitle>Postgrad Med J</addtitle><description>Twenty cases of acute intermittent porphyria were studied during the acute phase. Cardiovascular manifestations were noted in all the cases, with tachycardia in 20 and with hypertension in 17. Propranolol in doses ranging from 20--200 mg was given to all the cases and produced adequate control of tachycardia and hypertension. At follow-up, smaller doses of propranolol were found to maintain the pulse rate and BP within normal limits and also to prevent acute attacks.</description><subject>Acute Disease</subject><subject>Blood Pressure - drug effects</subject><subject>Drug Administration Schedule</subject><subject>Heart Rate - drug effects</subject><subject>Humans</subject><subject>Porphyrias - drug therapy</subject><subject>Porphyrias - physiopathology</subject><subject>Propranolol - administration & dosage</subject><subject>Propranolol - therapeutic use</subject><issn>0032-5473</issn><issn>1469-0756</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1979</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkc1v1DAQxS1EgW3hzIXDSkgcirL1t50LEloKBVWFQ-E6miR2myWJg52g9r_HVapV4cJpRno_v5nxI-QloxvGhD4Zr_rdRqmNlnqjpH5EVkzqsqBG6cdkRanghZJGPCOHKe0oZcJI9pQ8UUyWgq3I228xjBGH0IVu3Q5rrOfJ5WZysW-nyQ3TegxxvL6NLT4nBx675F7c1yPy_ePp5fasOP_66fP2_XlRSWungtciW-umFK7xwlBqbSWx8dxX3nv0iJobwRr0zLvaSN0gb1BXtdUWS47iiLxbfMe56l1T5yUidjDGtsd4CwFb-FsZ2mu4Cr-BS26psdngzb1BDL9mlybo21S7rsPBhTmBkVZTU_IMvv4H3IU5Dvk4YMZQy4RgKlMnC1XHkFJ0fr8Ko3AXAtyFAEpBDgFyCPnFq4cX7Pnl17NcLHKbJnezVzH-BG2EUXDxYwtnTF2oL5db-JD544Wv8pj_zf4DXDehOg</recordid><startdate>19790801</startdate><enddate>19790801</enddate><creator>Menawat, A. S.</creator><creator>Panwar, R. B.</creator><creator>Kochar, D. K.</creator><creator>Joshi, C. K.</creator><general>The Fellowship of Postgraduate Medicine</general><general>Oxford University Press</general><general>BMJ Group</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19790801</creationdate><title>Propranolol in acute intermittent porphyria</title><author>Menawat, A. S. ; Panwar, R. B. ; Kochar, D. K. ; Joshi, C. K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b488t-2c39316d93edf370088b4adf2fbfffafaa62731daf1fec746da2da6bc868a92a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1979</creationdate><topic>Acute Disease</topic><topic>Blood Pressure - drug effects</topic><topic>Drug Administration Schedule</topic><topic>Heart Rate - drug effects</topic><topic>Humans</topic><topic>Porphyrias - drug therapy</topic><topic>Porphyrias - physiopathology</topic><topic>Propranolol - administration & dosage</topic><topic>Propranolol - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Menawat, A. S.</creatorcontrib><creatorcontrib>Panwar, R. B.</creatorcontrib><creatorcontrib>Kochar, D. K.</creatorcontrib><creatorcontrib>Joshi, C. K.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>PHMC-Proquest健康医学期刊库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Postgraduate medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Menawat, A. S.</au><au>Panwar, R. B.</au><au>Kochar, D. K.</au><au>Joshi, C. K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Propranolol in acute intermittent porphyria</atitle><jtitle>Postgraduate medical journal</jtitle><addtitle>Postgrad Med J</addtitle><date>1979-08-01</date><risdate>1979</risdate><volume>55</volume><issue>646</issue><spage>546</spage><epage>547</epage><pages>546-547</pages><issn>0032-5473</issn><eissn>1469-0756</eissn><abstract>Twenty cases of acute intermittent porphyria were studied during the acute phase. Cardiovascular manifestations were noted in all the cases, with tachycardia in 20 and with hypertension in 17. Propranolol in doses ranging from 20--200 mg was given to all the cases and produced adequate control of tachycardia and hypertension. At follow-up, smaller doses of propranolol were found to maintain the pulse rate and BP within normal limits and also to prevent acute attacks.</abstract><cop>England</cop><pub>The Fellowship of Postgraduate Medicine</pub><pmid>514931</pmid><doi>10.1136/pgmj.55.646.546</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0032-5473 |
| ispartof | Postgraduate medical journal, 1979-08, Vol.55 (646), p.546-547 |
| issn | 0032-5473 1469-0756 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2428078 |
| source | MEDLINE; PubMed Central(OpenAccess); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Acute Disease Blood Pressure - drug effects Drug Administration Schedule Heart Rate - drug effects Humans Porphyrias - drug therapy Porphyrias - physiopathology Propranolol - administration & dosage Propranolol - therapeutic use |
| title | Propranolol in acute intermittent porphyria |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T10%3A02%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Propranolol%20in%20acute%20intermittent%20porphyria&rft.jtitle=Postgraduate%20medical%20journal&rft.au=Menawat,%20A.%20S.&rft.date=1979-08-01&rft.volume=55&rft.issue=646&rft.spage=546&rft.epage=547&rft.pages=546-547&rft.issn=0032-5473&rft.eissn=1469-0756&rft_id=info:doi/10.1136/pgmj.55.646.546&rft_dat=%3Cproquest_pubme%3E3972277221%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1770813315&rft_id=info:pmid/514931&rfr_iscdi=true |